Substrate reduction therapy in mouse models of the glycosphingolipidoses.

Eitemau Tebyg

• Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
  gan: Butters, T, et al.
  Cyhoeddwyd: (2005)
• Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
  gan: Butters, T, et al.
  Cyhoeddwyd: (2005)
• Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
  gan: Andersson, U, et al.
  Cyhoeddwyd: (2004)
• Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease
  gan: Ulrika Andersson, et al.
  Cyhoeddwyd: (2004-08-01)
• Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis.
  gan: Elliot-Smith, E, et al.
  Cyhoeddwyd: (2008)